Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Semin Respir Crit Care Med. 2013 Dec;34(6):855-66. doi: 10.1055/s-0033-1358557. Epub 2013 Nov 20.
Thoracic surgery is a dynamic field, and many scientific, technological, technical, and organizational changes are occurring. A prominent example is the use of less invasive approaches to major resection of non-small cell lung cancer (NSCLC), both thoracoscopic and robotic. Sophisticated technology corroborated by clinical data has led to these approaches becoming accepted additions to the armamentarium. Additionally, improvements in perioperative pain management have also contributed to dramatically changing the experience of patients who undergo modern thoracic surgery. Lung cancer is being detected more often at an early stage. At the same time, advances in techniques, patient care, clinical science, and multidisciplinary treatment support an increased role for aggressive resection in the face of larger locally advanced tumors or for those with limited metastatic disease. These advances, conducted in the setting of multidisciplinary decision making, have resulted in real and palpable advancements for patients with lung cancer.
胸外科是一个充满活力的领域，许多科学、技术、技术和组织上的变化正在发生。一个突出的例子是使用微创方法对非小细胞肺癌（NSCLC）进行大切除，包括胸腔镜和机器人手术。临床数据证实的复杂技术使得这些方法成为了一种公认的治疗手段。此外，围手术期疼痛管理的改善也极大地改变了接受现代胸外科手术的患者的体验。肺癌在早期被更频繁地发现。与此同时，技术、患者护理、临床科学和多学科治疗方面的进步支持在面对更大的局部晚期肿瘤或转移性疾病有限的患者时，积极进行切除的作用。这些进步是在多学科决策的背景下进行的，为肺癌患者带来了实实在在的进步。
